tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Financial Statements

Compare
16 Followers

Prescient Therapeutics Limited Financial Overview

Prescient Therapeutics Limited's market cap is currently AU$87.28M. The company's EPS TTM is AU$-0.006; its P/E ratio is -9.34; Prescient Therapeutics Limited is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Gross ProfitAU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Operating IncomeAU$ -7.54MAU$ -7.19MAU$ -9.89MAU$ -7.10MAU$ -5.43M
EBITDAAU$ -7.54MAU$ -7.19MAU$ -7.46MAU$ -6.86MAU$ -5.32M
Net IncomeAU$ -7.32MAU$ -8.24MAU$ -7.00MAU$ -5.12MAU$ -4.15M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 6.93MAU$ 14.51MAU$ 21.92MAU$ 12.28MAU$ 16.12M
Total AssetsAU$ 14.56MAU$ 20.39MAU$ 28.11MAU$ 17.62MAU$ 20.97M
Total DebtAU$ 0.00AU$ 330.49KAU$ 0.00AU$ 0.00AU$ 165.83K
Net DebtAU$ -6.91MAU$ -10.16MAU$ -5.90MAU$ -12.26MAU$ -15.93M
Total LiabilitiesAU$ 3.17MAU$ 2.33MAU$ 2.03MAU$ 856.01KAU$ 539.68K
Stockholders' EquityAU$ 11.39MAU$ 18.07MAU$ 26.08MAU$ 16.76MAU$ 20.43M
Cash Flow
Free Cash FlowAU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.32MAU$ -3.97M
Operating Cash FlowAU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.31MAU$ -3.97M
Investing Cash FlowAU$ 4.00MAU$ 12.00MAU$ -16.00MAU$ -4.43KAU$ -2.31K
Financing Cash FlowAU$ -330.49KAU$ 18.15KAU$ 15.83MAU$ 428.29KAU$ 12.75M
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Prescient Therapeutics Limited Debt to Assets

Prescient Therapeutics Limited Cash Flow

Prescient Therapeutics Limited Forecast EPS vs Actual EPS